Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Mehra

Showing results (271-280 of 347) with videos related to

Pageof 35
Sort By:
The American Journal of Pathology|March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate CancerMichael C Haffner, Gunes Guner, Diana Taheri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 26, 2017
Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assaysStephanie L Skala, Hong Xiao, Aaron M Udager, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven MalignanciesTongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Cells|August 12, 2022
Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer PatientsAnindita Ravindran, Kimiko L Krieger, Akash K Kaushik, et al.
Mayo Clinic Proceedings|June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling InhibitorsSounak Gupta, Paige Nichols, Christine M Lohse, et al.
European Urology|July 24, 2018
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic ImplicationsDaniel H Hovelson, Aaron M Udager, Andrew S McDaniel, et al.
Science (New York, N.Y.)|June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticitySanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2021
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinomaXiao-Ming Wang, Yuping Zhang, Rahul Mannan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
The American Journal of Surgical Pathology|October 11, 2019
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic CorrelationsSounak Gupta, Pedram Argani, Achim A Jungbluth, et al.
Pageof 35

Showing results (271-280 of 347) with videos related to

Sort By:
Pageof 35
The American Journal of Pathology|March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate CancerMichael C Haffner, Gunes Guner, Diana Taheri, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 26, 2017
Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assaysStephanie L Skala, Hong Xiao, Aaron M Udager, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven MalignanciesTongchen He, Lanbo Xiao, Yuanyuan Qiao, et al.
Cells|August 12, 2022
Uridine Diphosphate Glucuronosyl Transferase 2B28 (UGT2B28) Promotes Tumor Progression and Is Elevated in African American Prostate Cancer PatientsAnindita Ravindran, Kimiko L Krieger, Akash K Kaushik, et al.
Mayo Clinic Proceedings|June 26, 2022
Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling InhibitorsSounak Gupta, Paige Nichols, Christine M Lohse, et al.
European Urology|July 24, 2018
Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic ImplicationsDaniel H Hovelson, Aaron M Udager, Andrew S McDaniel, et al.
Science (New York, N.Y.)|June 26, 2025
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticitySanjana Eyunni, Rahul Mannan, Yuping Zhang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 15, 2021
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinomaXiao-Ming Wang, Yuping Zhang, Rahul Mannan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
The American Journal of Surgical Pathology|October 11, 2019
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic CorrelationsSounak Gupta, Pedram Argani, Achim A Jungbluth, et al.
Pageof 35